Skip to content

Clinical trials

Fabry Disease trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fabry Disease Phase: Not applicable Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20101
20111
20121
20131
20151
20162
20171
20192
20203
20213
20221
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting4
Unknown status3
Active, not recruiting1
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Hospital, Bordeaux4
Massachusetts General Hospital2
Centre Hospitalier Universitaire de Nice1
Federico II University1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
General University Hospital, Prague1
Hospices Civils de Lyon1
Institut National de la Santé Et de la Recherche Médicale, France1
M.A.G.I.C. Clinic LTD1
The Children's Hospital of Zhejiang University School of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fabry Disease23
Chronic Pain2
Gaucher Disease2
Mitochondrial Diseases2
Amyloidosis1
Cardiomyopathy, Hypertrophic1
Ehlers-Danlos Syndrome1
Glycogen Storage Disease Type II1
Hypertrophy, Left Ventricular1
Ischemic Stroke1

Trials

Showing 51 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.